Composition
- Active ingredients
- RIBOCICLIB SUCCINATE EQ 200MG BASE
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA209092.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Kisqali
- Active substance
- ribociclib succinate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Novartis
- Status
- Prescription
- FDA approval
- 13 Mar 2017
- Application
- NDA209092-001